1. Home
  2. FLS vs GKOS Comparison

FLS vs GKOS Comparison

Compare FLS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLS

Flowserve Corporation

HOLD

Current Price

$79.39

Market Cap

9.6B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$184.89

Market Cap

10.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLS
GKOS
Founded
1790
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.9B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
FLS
GKOS
Price
$79.39
$184.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
12
Target Price
$86.00
$126.92
AVG Volume (30 Days)
1.6M
899.4K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
1.04%
N/A
EPS Growth
23.36
N/A
EPS
1.41
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$6.80
$23.32
Revenue Next Year
$6.22
$27.43
P/E Ratio
$55.39
N/A
Revenue Growth
N/A
32.33
52 Week Low
$48.71
$73.16
52 Week High
$92.41
$191.62

Technical Indicators

Market Signals
Indicator
FLS
GKOS
Relative Strength Index (RSI) 57.52 68.27
Support Level $76.48 $96.44
Resistance Level $82.33 N/A
Average True Range (ATR) 2.09 5.90
MACD -0.19 -0.20
Stochastic Oscillator 47.17 76.73

Price Performance

Historical Comparison
FLS
GKOS

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: